Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Finasteride may not affect gynecomastia recurrence after mastectomy.

The GPRC6A-Duox1 axis helps control hair growth and loss by affecting hydrogen peroxide production.

HA-stimulated stem cell vesicles improved hair growth in male mice with androgenetic alopecia.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Minoxidil helps stabilize hair loss, increase density, and reduce shedding after hair transplant surgery.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Treat pattern hair loss with finasteride and topical minoxidil.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Researchers made two new compounds that could be used for medicine.

New treatments for hair loss are being developed using molecular biology.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.